Tvardi Therapeutics (TVRD) Receivables (2014 - 2025)
Tvardi Therapeutics (TVRD) posted Receivables of $2.24 million for Q1 2025, up 0.6% from $2.22 million a year earlier but down 50.2% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Receivables (2014 - 2025) Analysis & Trends
At the end of FY2024, Tvardi Therapeutics' Receivables came in at $4.5 million, up 35.4% from FY2023.
- Annual Receivables shows a five-year compound annual growth rate of 35.9% (FY2019 to FY2024).
- In prior years, Tvardi Therapeutics' Receivables was $3.32 million in FY2023 (-11.6%), $3.76 million in FY2022 (+725.5%), $455,000 in FY2021 (-18.3%) and $557,000 in FY2020 (-42.6%).
- Quarterly Receivables has run from a low of $305,000 in Q2 2021 to a high of $40.38 million in Q3 2021 over five years.
- On a year-over-year basis, Receivables increased in two of the last four quarters, with an average decline of 12.1%.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2022, with growth of 725.5%; the weakest was Q3 2024, with a decline of 72.8%.
- According to Business Quant data, Receivables for the three prior quarters was $4.5 million (Q4 2024), $1.37 million (Q3 2024) and $1.12 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | -95.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 2.22 Mn |
| Dec 31, 2023 | 3.32 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 455,000.00 |
| Sep 30, 2021 | 40.38 Mn |
| Jun 30, 2021 | 305,000.00 |
| Mar 31, 2021 | 4.14 Mn |
| Dec 31, 2020 | 557,000.00 |
| Sep 30, 2020 | 462,000.00 |
| Jun 30, 2020 | 486,000.00 |
| Mar 31, 2020 | 847,000.00 |
| Dec 31, 2019 | 971,000.00 |
| Sep 30, 2019 | 784,000.00 |
| Jun 30, 2019 | 605,000.00 |
| Mar 31, 2019 | 1.02 Mn |
API Access
Tvardi Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();